Efficacy and Safety of XP12B in Women With Menorrhagia

Completed · Phase 3 · Has a placebo group

Conditions studied: Menorrhagia, Heavy Menstrual Bleeding

In brief

The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.

Key facts

Study ID

NCT00401193

Run by

Ferring Pharmaceuticals

People needed

304

Starts

2006-11-01

Expected to finish

2008-05-01

Last updated by the study team

2015-05-13

Who can join

Age: 18 and older, up to 49. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with menorrhagia
• 18-49 years of age
• Regularly occurring menstrual periods

You may not qualify if…

• History or presence of clinically significant disease or abnormalities that may confound the study
• History of bilateral oophorectomy or hysterectomy
• Hormone therapy for birth control

Where it is running

• Investigative Site — Phoenix, Arizona, United States
• Investigative Site — Tucson, Arizona, United States
• Investigative Site — Tucson, Arizona, United States
• Investigative Site — Little Rock, Arkansas, United States
• Investigative Site — Searcy, Arkansas, United States
• Investigative Site — Los Alamitos, California, United States
• Investigative Site — Los Angeles, California, United States
• Investigative Site — San Diego, California, United States
• Investigative Site — Denver, Colorado, United States
• Investigative Site — Groton, Connecticut, United States
• Investigative Site — Gainesville, Florida, United States
• Investigative Site — Jacksonville, Florida, United States
• Investigative Site — Lighthouse PT, Florida, United States
• Investigative Site — Miami, Florida, United States
• Investigative Site — Miami Beach, Florida, United States
• Investigative Site — New Port Richey, Florida, United States
• Investigative Site — Sarasota, Florida, United States
• Investigative Site — Atlanta, Georgia, United States
• Investigative Site — Decatur, Georgia, United States
• Investigative Site — Boise, Idaho, United States
• Investigative Site — Idaho Falls, Idaho, United States
• Investigative Site — Bloomington, Indiana, United States
• Investigative Site — Newton, Kansas, United States
• Investigative Site — Overland Park, Kansas, United States
• Investigative Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.